Related Experiment Video

Updated: Jun 30, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction

Giuseppe De Luca1, Stefano Savonitto, Cesare Greco

  • 1Division of Cardiology, 'Maggiore della Carità' Hospital, Eastern Piedmont University 'A. Avogadro', and Centro di Biotecnologie per la Ricerca Medica Applicata (BRMA), Novara, Italy. giuseppe.deluca@med.unipmn.it

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|September 19, 2008
PubMed

Insights

Identifying patients at risk for cardiogenic shock after ST-segment elevation myocardial infarction is crucial. Key predictors include Killip class >1, low blood pressure, older age, and diabetes, guiding preventative strategies.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Critical Care Medicine

Background:

  • ST-segment elevation myocardial infarction (STEMI) can lead to cardiogenic shock.
  • Early identification of high-risk patients is vital for improved outcomes.
  • The BLITZ-1 study investigated predictors and outcomes of cardiogenic shock in STEMI patients.

Purpose of the Study:

  • To identify clinical predictors of cardiogenic shock development during hospitalization in STEMI patients.
  • To describe the outcomes of patients who developed cardiogenic shock.
  • To inform preventative strategies for cardiogenic shock in STEMI.

Main Methods:

  • Nationwide survey of acute myocardial infarction patients in coronary care units (October 2001).
  • Included patients with ST-segment elevation myocardial infarction or left bundle branch block/pacemaker.
  • 30-day follow-up for major cardiac events post-discharge.

Main Results:

  • 1345 patients analyzed; 97 (7.2%) developed cardiogenic shock.
  • 71 patients developed shock during hospitalization; 26 upon admission.
  • Independent predictors for in-hospital shock: Killip class >1, low systolic BP, older age, unsuccessful reperfusion, diabetes.
  • Mortality was high in both groups (71.8% for in-hospital shock, 65.4% for admission shock).

Conclusions:

  • Most cardiogenic shock in STEMI occurs post-initial hospitalization.
  • Patients with Killip class >1, low systolic BP, and advanced age are at higher risk.
  • Early identification enables aggressive therapies (pharmacological, mechanical support, revascularization) to prevent shock.
Abstract

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...